Jun 26, 2023 07:00AM
Jun 21, 2023 07:00AM
Jun 21, 2023 07:00AM
Jun 2, 2023 09:00AM
May 24, 2023 07:00AM
Apr 26, 2023 07:00AM
Apr 19, 2023 07:00AM Chemomab Therapeutics to Present at Upcoming Scientific Conferences
Apr 12, 2023 07:00AM
Mar 29, 2023 08:30AM
Mar 17, 2023 07:00AM
Feb 21, 2023 07:01AM
Feb 21, 2023 07:00AM
Jan 3, 2023 07:02AM
Jan 3, 2023 07:00AM Chemomab Reports Top-Line Results from CM-101 Phase 2a Liver Fibrosis Biomarker Trial in NASH Patients
Dec 21, 2022 07:01AM
Dec 21, 2022 07:00AM
Nov 30, 2022 07:00AM
Nov 14, 2022 07:04AM
Nov 14, 2022 07:00AM
Nov 9, 2022 08:02AM
Nov 1, 2022 07:00AM Chemomab Therapeutics to Report Third Quarter 2022 Financial Results and Provide a Business Update
Aug 12, 2022 06:00AM
Aug 12, 2022 06:00AM
Jun 28, 2022 07:02AM
Jun 28, 2022 07:00AM
Jun 2, 2022 07:00AM
May 18, 2022 07:00AM
May 4, 2022 07:00AM Chemomab Therapeutics to Report First Quarter 2022 Financial Results and Provide a Business Update
Mar 23, 2022 07:00AM
Mar 10, 2022 07:00AM
Feb 10, 2022 08:00AM
Dec 3, 2021 08:01AM
Dec 3, 2021 08:00AM
Dec 2, 2021 07:04AM
Dec 2, 2021 07:00AM Chemomab Announces FDA Clearance of Its IND Application for CM-101, a First-In-Class CCL24 Neutralizing Antibody for the Treatment of Primary Sclerosing Cholangitis
Jun 23, 2021 08:30AM
Jun 23, 2021 08:30AM

727 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All